DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

0.95 0.00 (-0.16%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LXRX $0.95 -0.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.95
Previous Close $0.95
Daily Range $0.95 - $0.99
52-Week Range $0.80 - $1.86
Market Cap $689.3M
P/E Ratio -5.01
Dividend (Yield) $0.00 (0.0%)
Volume 1,730,061
Average Daily Volume 2,721,258
Current FY EPS -$0.19

Sector

Healthcare

Industry

Drug Makers

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexpharma.com/

News & Commentary Rss Feed

7 States Where Diabetes Prevalence Is the Highest

More than 29 million people now have diabetes, but its occurrence is the highest within these seven U.S. states.

Lexicon Pharmaceuticals - A Diamond In The Rough?

Lexicon-Ipsen Agreement Expanded to Include Canada - Analyst Blog

8 Analyst Stocks Under $10 With Massive Upside Calls

Health Care Sector Update for 03/09/2015: LXRX, HTBX, CTIC

Lexicon Pharma Announces Closing of Enrollment in Pivotal Phase 3 Clinical Trial of Telotristat Etip

Lexicon Pharma Announces Closing of Enrollment in Pivotal Phase 3 Clinical Trial of Telotristat Etiprate

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q4 2014 Results - Earnings Call Transcript

Morning Market Gainers

UPDATE: Lexicon Pharmaceuticals Shares Surge On Upbeat Q4 Results

Lexicon (LXRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

Lexicon Pharmaceuticals (LXRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tap

Lexicon Pharmaceuticals (LXRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

See More LXRX News...

LXRX's Top Competitors

LXRX $0.95 (-0.16%)
Current stock: LXRX
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB